Form 4: UnitedHealth Group Director Timothy Flynn Reports Stock Acquisition

Director Timothy Flynn reports acquisition of 161 shares of UnitedHealth Group common stock and indirect ownership of 2,000 shares via trust.

Summary

• On October 1, 2024, Timothy Patrick Flynn, a director of UnitedHealth Group, reported acquiring 161 shares of common stock.
• The acquisition was made at a price of $0 per share.
• Following the transaction, Flynn directly owns 10,181 shares of UnitedHealth Group common stock.
• Flynn also indirectly owns 2,000 shares through a trust.
• The 161 shares represent deferred stock units granted as quarterly compensation for service as a director.
• These deferred stock units are immediately vested but must be retained until completion of service on the Board.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and alignment of interests. There are no indications of negative events or concerns.

Positives

• The acquisition of shares by a director signals confidence in the company's future.
• The deferred stock units incentivize the director to remain with the company.

Future Outlook

The director is required to retain the deferred stock units until completion of service on the Board, aligning his interests with the long-term performance of the company.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies like UnitedHealth Group.

Comparison to Industry Standards

• Director compensation packages often include stock options and restricted stock units to align executive interests with shareholder value, a common practice among S&P 500 companies.
• Companies like Johnson & Johnson and Pfizer also utilize similar compensation strategies for their board members.

Stakeholder Impact

• The stock acquisition by a director can positively influence shareholder confidence.

Key Dates